섬유근통 증후군
Fibromyalgia Syndrome
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Fibromyalgia is a chronic syndrome, which is characterized by widespread pain, unrefreshed sleep, a disturbed mood and fatigue. Until more is understood about fibromyalgia and myofascial pain syndrome, the management issues concerning its treatment remain difficult and problematic. Symptom management, with emphasis on functional restoration, takes priority. Such treatment should ideally be offered as part of a multidisciplinary treatment program using both pharmacological and nonpharmacological treatment modalities. The critical components of any successful fibromyalgia treatment program include addressing physical fitness, work and other functional activities, as well as mental health, in addition to symptom-specific therapies. The pathophysiological differences between fibromyalgia and myofascial pain syndrome have not been clearly elucidated in the laboratory, and the terminology for these conditions has been confusing. The terms fibromyalgia and myofascial pain syndrome has been used generically to refer to this group of musculoskeletal disorders. Chronic fatigue syndrome may be listed in the future as a separate entity, but currently awaits further research efforts. The care of each patient has to be individualized, as all patients are unique, and astute, empathetic clinicians can make a difference to the suffering of patients with these disorders.
참고문헌 (38)
- Lawrence RC, "Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States", 16, pp.427~41 (1989)
- Wolfe F, "The prevalence and characteristics of fibromyalgia in the general population", 38, pp.19~28 (1995)
- Wolfe F, "The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia Report of the Multicenter Criteria Committee", pp.160~72
- Wolfe F, "Aspects of fibromyalgia in the general population", pp.151~6
- Croft P, "The prevalence of chronic widespread pain in the general population", 20, pp.710~3 (1993)
- Macfarlane GJ, "Chronic widespread pain in the community:the influence of psychological symptoms and mental disorder on healthcare seeking behavior", 26, pp.413~9 (1999)
- White KP, "the prevalence of fibromyalgia syndrome in London", pp.1570~6
- Buskila D, "The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services", 27, pp.1521~5 (2000)
- Holmes GP, "Chronic fatigue syndrome:a working case definition", 108, pp.387~9 (1988)
- Buchwald D, "Fibromyalgia and chronic fatigue syndrome:similarities and differences", 22, pp.219~43 (1996)
- Goldenberg DL, "High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice", 33, pp.381~7 (1990)
- Demitrack MA, "Chronic fatigue syndrome and fibromyalgia.Dilemmas in diagnosis and clinical management", 21, pp.671~92 (1998)
- Henriksson C, "Living with fibromyalgia.Consequences for everyday life", 8, pp.138~44 (1992)
- Henriksson C, "Impact of fibromyalgia on everyday life:a study of women in the USA and Sweden", 18, pp.241~8 (1996)
- Gerwin RD, "A study of 96 subjects examined both for fibromyalgia and myofascial pain", pp.1~
- Hong CZ, "Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points", 79, pp.863~72 (1998)
- Wolfe F, "a preliminary study of tender points and trigger points in persons with fibromyalgia", pp.944~51
- Coderre TJ, "Contribution of central neuroplasticity to pathological pain:review of clinical and experimental evidence", 52, pp.259~85 (1993)
- Bennett RM, "Emerging concepts in the neurobiology of chronic pain:evidence of abnormal sensory processing in fibromyalgia", 74, pp.385~98 (1999)
- Russell IJ, "Is there a metabolic basis for the fibrositis syndrome", pp.50~4
- Tunks E, "The reliability of examination for tenderness in patients with myofascial pain", pp.944~52
- Campbell SM, "Clinical characteristics of fibrositis controlled study of symptoms and tender points", pp.817~24
- Simms RW, "Tenderness in 75 anatomic sites.Distinguishing fibromyalgia patients from controls", 31, pp.182~7 (1988)
- Barsky AJ, "Functional somatic syndromes", 130, pp.910~21 (1999)
- Hadler NM, "Fibromyalgia:La Maladie est Morte", 24, pp.1250~1 (1997)
- White KP, "The London Fibromyalgia Epidemiology Study:comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls", 26, pp.1577~85 (1999)
- White KP, "Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London", pp.76~83
- White KP, "A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain", 27, pp.2677~82 (2000)
- Gagliese L, "Medically unexplained pain is not caused by psychopathology", 5, pp.251~7 (2000)
- Wolfe F, "A prospective,longitudinal,multicenter study of service utilization and costs in fibromyalgia", 40, pp.1560~70 (1997)
- Buskila D, "Fibromyalgia syndrome(FM)and nonarticular tenderness in relatives of patients with FM", 24, pp.941~4 (1997)
- Mense S, "Neurobiological concepts of fibromyalgia the possible role of descending spinal tracts", pp.113 24~9
- Weigent DA, "Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia", 315, pp.405~12 (1998)
- Melzack R, "Gate control theory:on the evolution of pain concepts", 5, pp.125~8 (1996)
- Russell IJ, "Fibromyalgia syndrome:approaches to management", 45, pp.1~4 (1996)
- Nyberg S, "Fluoxetine treatment of depression drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid", pp.586~96
- Russell IJ, "Efficacy of ultram treatment of fibromyalgia syndrome preliminary analysis of a multi-center"
- Russell IJ, "Efficacy of ultram treatment of fibromyalgia syndrome preliminary analysis of a multi-center"